Clinical Trials Directory

Trials / Completed

CompletedNCT01058525

Influence of Ultrasonographic Hydro-dissection With Glucose 5% on Nerve Block Efficiency

Influence of Ultrasonographic Hydro-dissection With Glucose 5% Solution on Median Nerve Block Efficiency: a Prospective and Randomized Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The real-time visualization of a needle and nerve during an ultrasound-guided nerve block can be challenging. These difficulties may partly explain the systemic complications of local anesthetics under ultrasound. Injection of small amounts of a solution around the anesthetized nerve (hydro-dissection) has been proposed to enhance contrast outlining its borders and also to improve the visualization of the needle tip. The glucose solution 5% solution is interesting because it allows, unlike saline, to maintain the motor response with neurostimulation. The hydro-dissection can be particularly useful when one suspect hypoechoic vessels near the nerve to be anesthetized. Thereby, the nerve well demarcated and separated from the vessels, injection of local anesthetic is performed in the circumferential diffusion space (like a small pocket) without redirecting needle. The influence of this hydro-dissection on the nerve block efficiency is unknown. The nerve block quality can be improved because the entire anesthetic is injected in contact with the nerve, but it can also be reduced due to the dilution of the local anesthetic by the glucose solution. In this randomized study, the investigators test the hypothesis that hydro-dissection does not alter the nerve block onset time.

Conditions

Interventions

TypeNameDescription
PROCEDUREmedian nerve blockmedian nerve block performed using ultrasound guidance
PROCEDUREmedian nerve block after hydro-dissectionmedian nerve block performed after hydro-dissection (glucose 5% solution), both using ultrasound guidance

Timeline

Start date
2010-01-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-01-28
Last updated
2016-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01058525. Inclusion in this directory is not an endorsement.